TIS 0.00% 0.0¢ tissue therapies limited

Sometime in early October last year in wrote: "Wouldn't it be...

  1. 227 Posts.
    lightbulb Created with Sketch. 2
    Sometime in early October last year in wrote:

    "Wouldn't it be better for TIS to get rid of all the stocks in storage?

    The current stock in storage will be 3 years old next month.
    By the time CE is approved & blah, blah it will be 3 1/2 years old maybe more."

    Should have thought of the cost of storage too.


    And also more CR coming soon.

    " The Company ............... anticipates targeting a further A$15 – 22 million later this year from international strategic investors to: o Complete final EMA review, to seek approval for CE Mark and proceed with targeted country sales launches in the EU and internationally; o Fund an FDA diabetic ulcer clinical trial to start during the second half of 2015. This clinical trial is expected to take 24 months and cost US$10 million; and o Provide working capital."

    Page 4 of Half yearly reports and accounts.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.